They can reduce levels of Bcl-2 and increase levels of Bax and caspase-3, two proteins that promote cell death, and trigger mitochondrial mediated apoptosis
While the exact reasons are still unclear, research suggests that they stem from a number of factors, like how long the GLP-1 agonists act in the body, their effects on the central nervous system, and their impact on general gastrointestinal functions, like how quickly your stomach empties
The timeline varies based on individual factors including starting weight, presence of sleep apnea, and sensitivity to the medication adjustment period
Months or even years after recovering from an initial SARS-CoV-2 infection, many people find themselves fighting a complex web of debilitating symptoms
Information on active UK trials can be found via the NHS Health Research Authority's Be Part of Research platform (bepartofresearch.nihr.ac.uk) or via ISRCTN.com and ClinicalTrials.gov